Literature DB >> 28389975

Assessment of apathy minimising the effect of motor dysfunctions in Parkinson's disease: a validation study of the dimensional apathy scale.

Gabriella Santangelo1,2, Alfonsina D'Iorio3, Fausta Piscopo3, Sofia Cuoco3,4, Katia Longo5, Marianna Amboni5,4, Chiara Baiano3, Domenico Tafuri6, Maria Teresa Pellecchia4, Paolo Barone4, Carmine Vitale5,6.   

Abstract

PURPOSE: Apathy is associated with motor symptoms in Parkinson's disease (PD); therefore, its evaluation could be influenced by motor disability. The Dimensional Apathy Scale (DAS) evaluates apathy excluding confounding effects of motor symptoms. The present study had three major aims: (a) to explore the psychometric properties of the DAS in non-demented PD patients; (b) to determine an optimal cut-off score of the DAS to identify apathetic PD patients; and (c) to determine a specific apathy profile in PD patients as compared to healthy controls (HC).
METHODS: One hundred and seven PD patients and 100 HC completed the DAS. To explore convergent and divergent validity of the DAS in PD, patients underwent the Apathy Evaluation Scale and tools for assessing depressive symptoms, anxiety and cognition. Clinical aspects were recorded. Receiver operating characteristic curve analyses were carried out to estimate the optimal cut-off score to identify clinically significant apathy.
RESULTS: The DAS scores showed high internal consistency and good evidence for convergent and discriminant validity. Maximum discrimination between apathetic and non-apathetic patients was obtained with a cut-off score of 28.5 (total score range: 0-72 with higher score indicating more severe apathy). Comparison between PD and HC groups revealed significant differences on total DAS, behavioural/cognitive initiation and emotional subscales.
CONCLUSIONS: The DAS is a valid and reliable tool to assess multidimensional apathy in PD, independently of severity of motor symptoms. Reduced initiation of thought and behaviour and emotional blunting characterised PD patients, without confounding effects of motor disability.

Entities:  

Keywords:  Apathy; Apathy scale; Depression; Non-motor symptoms; Parkinson’s disease

Mesh:

Year:  2017        PMID: 28389975     DOI: 10.1007/s11136-017-1569-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

1.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

2.  Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 3.  Empathy: gender effects in brain and behavior.

Authors:  Leonardo Christov-Moore; Elizabeth A Simpson; Gino Coudé; Kristina Grigaityte; Marco Iacoboni; Pier Francesco Ferrari
Journal:  Neurosci Biobehav Rev       Date:  2014-09-16       Impact factor: 8.989

4.  Characteristics of apathy in Parkinson's disease.

Authors:  Kathy Dujardin; Pascal Sockeel; David Devos; Marie Delliaux; Pierre Krystkowiak; Alain Destée; Luc Defebvre
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

5.  The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.

Authors:  P Sockeel; K Dujardin; D Devos; C Denève; A Destée; L Defebvre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

6.  Apathy in amyotrophic lateral sclerosis: insights from Dimensional Apathy Scale.

Authors:  Gabriella Santangelo; Mattia Siciliano; Luigi Trojano; Cinzia Femiano; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Francesca Trojsi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-21       Impact factor: 4.092

7.  Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.

Authors:  V Isella; C Mapelli; N Morielli; D De Gaspari; C Siri; G Pezzoli; A Antonini; M Poletti; U Bonuccelli; L Picchi; A Napolitano; M Vista; A Greco; I M Appollonio
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

8.  Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.

Authors:  Gabriella Santangelo; Carmine Vitale; Marina Picillo; Marcello Moccia; Sofia Cuoco; Katia Longo; Domenica Pezzella; Assunta di Grazia; Roberto Erro; Maria Teresa Pellecchia; Marianna Amboni; Luigi Trojano; Paolo Barone
Journal:  Parkinsonism Relat Disord       Date:  2015-08-21       Impact factor: 4.891

Review 9.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

10.  Developing a new apathy measurement scale: Dimensional Apathy Scale.

Authors:  Ratko Radakovic; Sharon Abrahams
Journal:  Psychiatry Res       Date:  2014-06-19       Impact factor: 3.222

View more
  8 in total

1.  A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease.

Authors:  Alfonsina D'Iorio; Chiara Baiano; Giovanna Maraucci; Carmine Vitale; Marianna Amboni; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2022-05-10       Impact factor: 3.830

2.  Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Trevor T-J Chong; Julie C Stout
Journal:  Mov Disord Clin Pract       Date:  2021-02-12

3.  Dissociable Motivational Deficits in Pre-manifest Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Julie C Stout; Trevor T-J Chong
Journal:  Cell Rep Med       Date:  2020-11-30

4.  Heightened effort discounting is a common feature of both apathy and fatigue.

Authors:  Mindaugas Jurgelis; Wei Binh Chong; Kelly J Atkins; Patrick S Cooper; James P Coxon; Trevor T-J Chong
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

5.  Apathy and actions- another consideration when theorizing about embodied nature of language in Parkinson's disease.

Authors:  Logan Wolff; Jared F Benge; Samia Ortiz-Hernandez; Samantha Beevers; Alexandra Armitage; Jungjun Park; Daniel L Drane
Journal:  J Commun Disord       Date:  2021-07-28       Impact factor: 1.864

6.  Differential impact of behavioral, social, and emotional apathy on Parkinson's disease.

Authors:  Yuen-Siang Ang; Patricia L Lockwood; Annika Kienast; Olivia Plant; Daniel Drew; Elitsa Slavkova; Marin Tamm; Masud Husain
Journal:  Ann Clin Transl Neurol       Date:  2018-08-14       Impact factor: 4.511

7.  Apathy and Anhedonia: Clinical and Neurophysiological Assessment of a Romanian Cohort.

Authors:  Diana Sipos-Lascu; Ștefan-Cristian Vesa; Lăcrămioara Perju-Dumbravă
Journal:  Brain Sci       Date:  2021-05-31

8.  Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.

Authors:  Vasileia Aristotelidou; Marianna Tsatali; Paul G Overton; Ana B Vivas
Journal:  PLoS One       Date:  2021-09-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.